SequelSEC

Scientist Home Future Health Ltd SHFH

Perfumes, Cosmetics & Other Toilet Preparations · CIK 0002032609 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$82.88K
Fiscal year ended 2026-06-30
Operating income
-$97.85K
Fiscal year ended 2026-06-30
Free cash flow
Unavailable
Fiscal year ended 2026-06-30

Scientist Home Future Health Ltd (SHFH) reported revenue of $82.88K and net income of -$97.85K for the fiscal year ended 2026-06-30. This page shows 7 annual periods of income statement, balance sheet and cash flow figures normalized from Scientist Home Future Health Ltd’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Perfumes, Cosmetics & Other Toilet Preparations.

Income

Scientist Home Future Health Ltd income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-09-30
Revenue$82.88K$188.76K$88.08K$39.60K$31.55K$44.82K$59.36K
Cost of revenue$55.19K$129.69K$55.49K$23.53K$18.01K$25.14K$32.97K
Gross profit$29.11K$59.07K$32.59K$16.07K$13.54K$19.69K$26.39K
Operating income-$97.85K-$102.07K-$152.73K-$47.84K-$38.15K$6.99K$1.93K
Net income-$97.85K-$102.07K-$152.73K-$47.84K-$37.21K$6.06K$175
Research & developmentUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Weighted-average diluted sharesshares 23.72Mshares 23.72MUnavailableshares 23.66Mshares 23.50Mshares 23.48Mshares 11.69M
Pretax income-$97.85K-$102.07K-$152.73K-$47.84K-$38.15K$6.99K$1.93K
Income tax expense$0$0$0$0-$935$935$1.75K
Diluted EPS$0.00$0.00Unavailable$0.00$0.00$0.00$0.00
Selling, general & administrative$126.96K$161.14K$185.32K$63.92K$51.69K$12.70K$24.46K
General & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

Scientist Home Future Health Ltd balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-09-30
Cash & equivalentsUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Total assets$529.84K$558.76K$644.36K$723.01K$114.72K$19.60K$46.38K
Current assets$125.32K$131.90K$192.25K$325.73K$114.72K$19.60KUnavailable
Total liabilities$616.17K$547.33K$530.97K$456.00K$63.18K$19.57KUnavailable
Current liabilities$340.30K$252.12K$214.46K$123.39K$63.18K$19.57KUnavailable
Total equity incl. NCI-$86.32K$11.43K$113.39K$267.00K$51.53K$27$9.14K
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Inventory$33.90K$31.38K$34.01K$1.99K$3.33K$3.46KUnavailable
Accounts receivableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
GoodwillUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debtUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts payableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Cash flow

Scientist Home Future Health Ltd cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-09-30
Operating cash flow-$12.84K-$71.81K-$138.80K-$99.35K-$5.29K-$4.83K-$9.46K
Capital expendituresUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Investing cash flowUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Financing cash flow$6.60K$18.51K$7.70K$265.48K$100.61K$2.35K$28.42K
Net change in cash-$6.28K-$53.56KUnavailableUnavailable$95.25K-$2.49KUnavailable
Stock-based compensationUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortizationUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Derived

Scientist Home Future Health Ltd derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-09-30
Free cash flowUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross margin35.1%31.3%37.0%40.6%42.9%43.9%44.5%
Operating margin-118.1%-54.1%-173.4%-120.8%-120.9%15.6%3.2%
FCF marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
SBC / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Current ratio0.37x0.52x0.90x2.64x1.82x1.00xUnavailable
Revenue YoY growth162.7%321.1%Unavailable-33.3%UnavailableUnavailableUnavailable
Net margin-118.1%Unavailable-173.4%-120.8%-117.9%Unavailable0.3%
R&D / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
CapEx / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailable13.4%90.9%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open SHFH in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-11View SEC filing
10-Q · Filed 2026-05-14View SEC filing
10-K · Filed 2026-03-27View SEC filing
10-Q · Filed 2025-11-12View SEC filing
10-Q · Filed 2025-08-12View SEC filing
10-Q · Filed 2025-05-15View SEC filing

Companies in the same industry

AXIL BNKK CABR CL COTY DQWS EL ELF EPC IPAR KARX KVUE

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.